Net Debt Summary of UniPharma Co., Ltd.

UniPharma Co., Ltd.'s latest annual net debt in 2023 was -68.36 Million TWD , down -13.51% from previous year.
UniPharma Co., Ltd.'s latest quarterly net debt in 2024 Q2 was -26.29 Million TWD , up 14.05% from previous quarter.
UniPharma Co., Ltd. reported annual net debt of -60.22 Million TWD in 2022, up 12.67% from previous year.
UniPharma Co., Ltd. reported annual net debt of -68.96 Million TWD in 2021, down -19.39% from previous year.
UniPharma Co., Ltd. reported quarterly net debt of -26.29 Million TWD for 2024 Q2, up 14.05% from previous quarter.
UniPharma Co., Ltd. reported quarterly net debt of -68.36 Million TWD for 2023 FY, down -13.51% from previous quarter.

Annual Net Debt Chart of UniPharma Co., Ltd. (2023 - 2019)

Name	Net Debt	Net Debt Difference
Allied Biotech Corporation	178.11 Million TWD	138.384%
GeneFerm Biotechnology Co., Ltd.	31.92 Million TWD	314.142%
Easywell Biomedicals, Inc.	123.43 Million TWD	155.386%
TTY Biopharm Company Limited	-705.97 Million TWD	90.316%
Synmosa Biopharma Corporation	1.52 Billion TWD	104.494%
Orient EuroPharma Co., Ltd.	3.1 Billion TWD	102.201%
Center Laboratories, Inc.	3.91 Billion TWD	101.744%
Tien Liang BioTech Co., Ltd.	-57.55 Million TWD	-18.783%
Orient Pharma Co., Ltd.	633.6 Million TWD	110.79%
InnoPharmax Inc.	-17.85 Million TWD	-282.837%
Johnson Chemical Pharmaceutical Works Co., Ltd.	-926.77 Million TWD	92.623%
Excelsior Biopharma Inc.	-212.51 Million TWD	67.829%
DV Biomed Co., Ltd.	160.7 Million TWD	142.543%
Foresee Pharmaceuticals Co., Ltd.	-781.42 Million TWD	91.251%
Handa Pharmaceuticals, Inc.	-653.8 Million TWD	89.543%
Anxo Pharmaceutical Co., Ltd.	492.4 Million TWD	113.884%
Alar Pharmaceuticals Inc.	-738.05 Million TWD	90.737%
Winston Medical Supply Co., Ltd.	-191.81 Million TWD	64.357%
Mercury Biopharmaceutical Corporation	-1.94 Million TWD	-3415.013%
Bioray Biotech Co., Ltd	-27.23 Million TWD	-151.054%
TSH Biopharm Corporation Limited	-568.74 Million TWD	87.979%